Overview of Nucleocapsid-Targeting Vaccines against COVID-19
Alexandra Rak, Irina Isakova-Sivak, Larisa Rudenko, Seth Pincus · 2023
Read Overview of Nucleocapsid-Targeting Vaccines against COVID-19 by Alexandra Rak, Irina Isakova-Sivak, Larisa Rudenko, Seth Pincus (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10747980.txt.
Description
Alexandra Rak and co-authors review vaccines that target the nucleocapsid protein of the COVID-19 virus, in a 2023 paper. Most licensed vaccines aim at the spike protein. Spike changes fast, so variant strains partly escape those vaccines. The nucleocapsid protein, which packs the virus genome, changes far less.
A vaccine aimed at that stable part could guard against many variants at once. The review gathers what is known about such vaccine designs. It weighs their immune effects and early test results. The authors see nucleocapsid as a strong partner or backup to spike. Broad vaccines matter as the virus keeps evolving.
Catalog record
| CREATOR | Alexandra Rak, Irina Isakova-Sivak, Larisa Rudenko, Seth Pincus |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |